Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic Methods

Completed

Conditions studied: Prostate Cancer

In brief

This study will examine prostate tumor tissue cultures to try to identify genetic abnormalities that contribute to the cause or progression of the disease. Patients with prostate cancer enrolled in the National Cancer Institute protocol 97-C-0147 (Collection of Serum and Tissue Samples from Patients with Biopsy-Proved or Suspected Malignant Disease) may be eligible for this study. Specimens for tissue culture for this study will be obtained from tumors surgically removed from patients participating in NCI protocol 97-C-0146. The findings of this study may lead to better methods of predicting the course of disease in individual patients.

Key facts

Study ID

NCT00022919

Run by

National Human Genome Research Institute (NHGRI)

People needed

150

Starts

2001-08-01

Expected to finish

2004-08-01

Last updated by the study team

2008-03-04

Who can join

Age: any. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Only patients who have met pathologic criteria for prostate intraepithelial neoplasia or higher (determined by pathologists included in the NCI protocol) will be included for entry into this protocol.

You may not qualify if…

• No prisoners, decisionally impaired, healthy volunteers, or lab personnel will be included in this study.

Where it is running

• National Human Genome Research Institute (NHGRI) — Bethesda, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.